Document:

Exhibit
10.1

 

MUTUAL
RELEASE AND NON-DISPARAGEMENT AGREEMENT

[Immune
Therapeutics, Inc. and Mr. Michael K. Handley]

 

This
Mutual Release and Non-Disparagement Agreement (the “Agreement”) is entered into on April 26, 2020, by and between
Michael K. Handley (“Mr. Handley”), a resident of the State of Colorado, and Immune Therapeutics, Inc. (the “Company”),
a Florida Corporation.

 

PURPOSE

 

The
mutual release is intended to affect the termination of any obligations by either party as hereinafter designated. The mutual
non-disparagement is intended to affect an enforceable prohibition of disparagement of one party by the other as described herein.
The parties are advised to seek independent legal counsel with respect to entering into this Agreement.

 

RECITALS

 

WHEREAS,
Mr. Handley submitted his resignation to a quorum of the Board of Directors of the Company from all of Mr. Handley’s positions
held with the Company, inclusive of President, Chief Executive Officer, and Director, on April 21, 2020, and again on April 24,
2020 at a formal meeting of the Board of Directors held between approximately 4 pm EDT and 4:15 pm EDT on that day, and the Board
of Directors duly accepted such resignation effective immediately;

 

WHEREAS,
Mr. Handley and the Members of the Board of Directors expressed a sincere intention to amicably and professionally execute the
immediate transition for the benefit of the parties, shareholders, and other stakeholders;

 

WHEREAS,
both parties recognize that such an amicable and professional transition is best achieved through a mutual release of liabilities
between the parties and a mutual commitment of non-disparagement of one party in respect of the other party;

 

WHEREAS,
both parties recognize that by the execution of the mutual release contained in this Agreement, they each are agreeing on their
own behalf and for any of their heirs and assigns, to expressly release the other party inclusive of any of the other party’s
heirs and assigns, from all liability for claims and/or demands which may arise from the employment of Mr. Handley by the Company,
the employment contract dated September 20, 2019, whether or not existing prior to the resignation, executed between the parties
as evidenced by the signatures of Ms. Noreen Griffin, the Chief Executive Officer of the Company prior to and including some segment
of September 20, 2019, and Mr. Handley (for reference, attached hereto or accompanying the Agreement as Annex A), and any
follow-on agreements between the parties up to and including April 24, 2020 (all herein referred to as the “Employment
and Contract”);

 

WHEREAS,
the parties to this Agreement desire to provide releases under the terms and conditions set forth herein;

 

WHEREAS,
both parties to this Agreement recognize that by the execution of the non-disparagement conditions contained in this agreement,
they each are agreeing on their own behalf and for any of their heirs and assigns, from engaging in any disparagement of one party
in respect of the other party, under the terms and conditions set forth herein;

 

    	Page 1 of  3	Initials: MH _____ and RM ____ & CJ ____

     

    

 

NOW,
THEREFORE, in consideration of the promises and the mutual covenants and agreements contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound
hereby, agree as follows:

 

WITNESSETH

 

1.
Mr. Handley does hereby release, cancel, forgive and forever discharge the Company and each of its predecessors, parent corporations,
holding companies, subsidiaries, affiliates, divisions, heirs, successors and assigns, and all of their officers, directors, consultants,
attorneys, agents, auditors, and employees from all actions, claims, demands, damages, obligations, liabilities, controversies
and executions, of any kind or nature whatsoever, whether known or unknown, whether suspected or not, which have arisen, or may
have arisen, or shall arise by reason of the Employment and Contract, defined above, from the first day of the world, including
this day and each day hereafter, and Mr. Handley does specifically waive any claim or right to assert any cause of action or alleged
case of action or claim or demand which has, through oversight or error intentionally or unintentionally or through a mutual mistake,
been omitted from the release provisions of this Agreement.

 

2.
The Company does hereby release, cancel, forgive and forever discharge Mr. Handley and each of his holding companies, subsidiaries,
affiliates, divisions, successors, heirs, and assigns in all capacities whatsoever, including without limitation as an officer,
director, employee, representative, designee, agent, and shareholder thereof, from all actions, claims, demands, damages, obligations,
liabilities, controversies and executions, of any kind or nature whatsoever, whether known or unknown, whether suspected or not,
which have arisen, or may have arisen, or shall arise by reason of any matter, cause or thing whatsoever related to the Employment
and Contract, from the first day of the world, including this day and each day hereafter, and the Company does specifically waive
any claim or right to assert any cause of action or alleged cause of action or claim or demand which has, through oversight or
error, intentionally or unintentionally or through a mutual mistake, been omitted from the release provisions of this Agreement.

 

3.
Each of the parties agrees not to make any statements, written or verbal, or cause or encourage others to make any statements,
written or verbal, that defame, disparage or in any way criticize the personal or business reputation, practices, or conduct of
the other party, its employees, directors, officers, attorneys, consultants, or agents relating to or arising out of the Employment
and Contract. The parties acknowledge and agree that this prohibition extends to statements, written or verbal, made to anyone,
including but not limited to, the news media, investors, potential investors, any board of directors or advisory board
or directors, industry analysts, competitors, strategic partners, vendors, employees (past and present), and clients.

 

Applicable
Law. This Agreement shall be construed under and in accordance with the laws of the State of Florida.

 

    	Page 2 of  3	Initials: MH _____ and RM ____ & CJ ____

     

    

 

Legal
Construction. In the event any one or more of the provisions contained in this Agreement shall for any reason be held invalid,
illegal, or unenforceable in any respect, that invalidity, illegality, or unenforceability shall not affect any other provision.
This Agreement shall be construed as if the invalid, illegal, or unenforceable provision had never been contained in it. The provisions
of this Agreement must be read as a whole and are not severable and/or separately enforceable by either party hereto.

 

Attorneys’
Fees. If any action at law or in equity is brought to enforce or interpret the provisions of this Agreement, the prevailing
party will be entitled to reasonable attorneys’ fees in addition to any other relief to which that party may be entitled.

 

Signatures.
This Agreement shall be executed on behalf of Mr. Handley by Michael K. Handley and on behalf of the Company both by Dr. Roscoe
M. Moore, Jr., Chairman of the Company’s Board of Directors and Chad S. Johnson, Esq., Independent Outside Counsel to the
Company’s Board of Directors. This Agreement may be executed in multiple duplicate
counterparts, each of which shall be deemed an original agreement and all of which shall constitute one and the same agreement.
The counterparts of this Agreement may be executed and delivered by facsimile or other electronic signature (including portable
document format or PDF) by either of the parties or any of the signatories, and the receiving party may rely on the receipt of
such document so executed and delivered electronically or by facsimile, as if the original had been received.

 

[Signatures
Immediately Follow]

 

	Mr.
    Handley	 	 
	 	 	 	 
	By:	 	(signature)	 
	 	Michael
    K. Handley 	 	 
	 	 	 	 
	The
    Company	 	 
	 	 	 	 
	By:	 	(signature)	 
	 	Dr.
    Roscoe Moore 	 	 
	 	Chairman
    of the Board 	 	 
	and	 	 
	 	 	 	 
	By:	 	(signature)	 
	 	Chad
    S. Johnson, Esq. 	 	 
	 	Board
    Counsel 	 	 

 

[Annex
A Is Attached Hereto or Accompanies this Agreement]

[End
of Document]

 

    	Page 3 of  3	Initials: MH _____ and RM ____ & CJ ____Exhibit
10.2

 

WRITTEN
CONSENT OF THE

BOARD
OF DIRECTORS OF IMMUNE THERAPEUTICS, INC.

 

The
undersigned, being all of the Directors (the “Directors”) of Immune Therapeutics, Inc., a Florida corporation (the
“Company”), required to enact these resolutions by majority, pursuant to Section 607.0821 of the Florida Business
Corporation Act and the Bylaws of the Company, hereby consent to the following actions and hereby adopt and approve the following
recitals and resolutions by written consent.

 

WHEREAS,
On April 29, 2020 Mr. Michael K. Handley resigned in a written instrument (the “Resignation Letter”) (“Exhibit
A”) from his positions as CEO, President, and Member of the Board of Directors of the Company (the “Board”).

 

WHEREAS,
On April 30, 2020 the Board accepted and ratified Mr. Handley’s written resignation and entered into a mutual release and
non-disparagement agreement (the “Agreement”) (“Exhibit B”) with him.

 

WHEREAS,
On April 30, 2020 the Board also appointed Director Kevin J. Phelps to serve as Interim CEO and President and proceeded to engage
a five (5) person transition team.

 

NOW,
THEREFORE, BE IT: 

 

RESOLVED,
that the resignations as expressed in the Resignation Letter of Mr. Michael Handley as CEO, President, and Director of the Company
are hereby accepted by the Board;

 

RESOLVED,
that Director Kevin J. Phelps is appointed to serve as Interim CEO and President and Mr. Phelps has accepted such appointment,
with any related compensation to be determined by Mr. Phelps and the Company within thirty (30) days;

 

RESOLVED,
that management of the Company will file the proper paperwork with the SEC and any other regulatory body to notify them of the
resignations of Mr. Handley, the entering into of the Agreement, and the appointments of Mr. Phelps within the relevant regulatory
time frames.

 

FURTHER
RESOLVED, that the Directors and Officers of the Company be, and each of them hereby is, authorized and directed to take all
such further actions and to execute and deliver, in the name of and on behalf of the Company, any and all such further documents,
agreements, instruments and undertakings deemed necessary to execute the intent and will of the Directors in these resolutions;

 

FURTHER
RESOLVED, that any and all actions taken by the Directors and Officers of the Company or their designees prior to the date
hereof and contemplated by the foregoing resolutions are hereby adopted and approved as the acts and deeds of the Company.

 

IN
WITNESS WHEREOF, the undersigned, do hereby certify that we are members of the Board of Directors of the Company; that the
aforementioned resolutions are duly adopted and ratified by the Board of Directors as of April 30, 2020, and held in accordance
with its Bylaws and the laws of the State of Florida; and that the same have not in any way been modified, repealed or rescinded
and are in full force and effect; and by the undersigned Directors, by their signatures hereunder, waive any requirement of notice
required by law or the Company’s Bylaws, and execute this written consent as of the 30h day of April, 2020; the undersigned
hereby agree that this written consent may be executed in one or more duplicate counterparts, each of which shall be deemed an
original, and all of which, when taken together, shall be deemed one action.

 

	 	 	 	 	 
	 	PRINTED:
    ROSCOE MOORE JR.	 	PRINTED:
    KEVIN PHELPS	 
	 	 	 	 	 
	 	 	 	 	 
	 	PRINTED:
    Michael Sander	 	PRINTED:
    CLIFFORD SELSKY

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]